Table 2.
Temporal intervals between date of symptoms onset, radiological diagnosis, cytohistological diagnosis, first oncological appointment, treatment start, and first radiological reassessment by year of diagnosis
| Time interval | 2019 Median, days (IQR) | 2020 Median, days (IQR) | P valuea |
|---|---|---|---|
| Symptom onset/radiological diagnosis | 28 (46) | 28 (49) | 0.94 |
| Symptom onset/cytohistological diagnosis | 48 (55) | 49 (57) | 0.92 |
| Symptom onset/first oncological appointment | 65 (72) | 63 (71.2) | 0.06 |
| Cytohistological diagnosis/first oncological appointment | 24 (25) | 20 (22) | <0.01b |
| Symptom onset/treatment start | 83 (71.2) | 78.5 (72) | 0.40 |
| Cytohistological diagnosis/treatment start | 35 (32) | 31 (29) | <0.01b |
| First oncological appointment/treatment start | 16 (21) | 15 (20) | 0.45 |
| Treatment start/first radiological evaluation | 71 (32.2) | 71.5 (36) | 0.33 |
IQR, interquartile range.
a
Mann-Whitney U test comparing time intervals between 2019 and 2020. P values were calculated excluding patients with unknown values. Data of patients who had their lung cancer diagnosis after first oncological appointment (as per standard practice of referral Hospitals) were also excluded in the calculation of these specific temporal intervals.
b
Statistically significant (P < 0.05).